Last reviewed · How we verify

NCT06698406

Transcultural Validation of the French Version of the " Patients' Endorsement of a Biopsychosocial Model of Chronic Pain " Scale

Completed Last updated 19 March 2026
What this trial tests

trial in Pain, Chronic in 80 participants. Completed in 26 February 2026.

Timeline
1 November 2024
Primary endpoint
26 February 2026
26 February 2026

Quick facts

Lead sponsorBenno Rehberg-Klug
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date1 November 2024
Primary completion26 February 2026
Estimated completion26 February 2026
Sites1 location across Switzerland

Conditions studied

Sponsor

Benno Rehberg-Klug

Who can join

18 and older, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will validate the French version of the "Patients' Endorsement of a Biopsychosocial model of chronic pain (PEB) scale" by comparing it to the "pain self-efficacy" questionnaire

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other Benno Rehberg-Klug trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06698406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing